Brittany M. Gouse, MD, MPH
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Psychiatry

MD/MPH, State University of New York Upstate Medical University
BS, Tulane University

Pronouns: she/her/hers



Dr. Brittany Gouse’s MD MPH is the Assistant Clinical Director of the Wellness and Recovery After Psychosis program and Assistant Professor of Psychiatry at Chobanian and Avedisian School of Medicine. She earned MD-MPH through the State University of New York Upstate Medical University and Syracuse University dual degree program. She completed both her Residency in Adult Psychiatry and Fellowship in Public Psychiatry at BU-BMC. Through her Fellowship in Public Psychiatry, Dr.Gouse specialized in the care of individuals living with schizophrenia and other forms of serious mental illness. She sees patients for psychopharmacology in the WRAP program.

Dr. Gouse’s research is predominantly in epidemiology, with a focus on studying the drivers of morbidity and premature mortality in schizophrenia. She co-directs WRAP’s Advancing Coordinated Care through Epidemiologic Studies in Schizophrenia (ACCESS) initiative. She is the recipient of the 2023-2025 BU Clinical and Translational Science Institute KL2 Award and the 2023-2025 American Psychiatric Association Research Fellowship.

Diversity, Equity, Inclusion and Accessibility

Structural inequities perpetuate disparities in access to opportunities in academia, particularly within clinical research. Individuals belonging to racial, ethnic, cultural, gender, linguistic and/or minority groups in the United States face significant barriers in pursuit of a career in clinical research (e.g. underrepresentation in leadership positions, implicit or explicit bias and discrimination). First generation scientists face a multitude of early challenges compared to their peers (e.g. lack of family connections in academia may mean more difficulty finding mentorship, often financial disadvantage). These are critical issues as lack of diversity in experiences and perspectives is a major detriment to scientific research. In particular, lack of diversity among clinical researchers perpetuates disparities in health outcomes among patients who belong to racial, ethnic, cultural, gender, and linguistic groups.

One of our research program’s core values is that you cannot have excellent science that drives innovation without diversity in perspectives and lived experiences. This is especially important given our focus on health disparities and inequities research in schizophrenia. To this end, we actively recruit and seek to retain team members from racial, ethnic, cultural, gender, and linguistic minority groups. We also actively encourage collaboration with researchers with lived experience with serious mental illness.

We proudly have a diverse and multidisciplinary clinical research team. It is the expectation that our research program is a community in which all persons feel valued and understood. This involves strategic mentorship, sponsorship, and creating a supportive environment where all feel comfortable raising any concerns.

As the first member in my family to pursue a graduate or professional degree, I have immensely benefited from longitudinal career mentorship from senior scientist. I seek to mentor and sponsor individuals from underrepresented groups in clinical research.

Psychiatrist
Boston Medical Center
Psychiatry





Sociodemographic and Clinical Predictors of Suicide in Early Psychosis
07/01/2023 - 06/30/2025 (PI)
American Psychiatric Association

Laboratory for Early Psychosis Research (LEAP) (Supplement 2)
01/01/2023 - 06/30/2023 (PI)
McLean Hospital National Institute o


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Gouse BM, Weinberg JM, Brown HE. Risk Stratification to Reduce Excess Mortality in Early Psychosis. JAMA Netw Open. 2024 Mar 04; 7(3):e240623.View Related Profiles. PMID: 38497967
     
  2. Gouse BM, Schwarz AG, Gibbs JS, Weinberg JM, Yue H, Chava A, Brown HE. Demographic predictors of lack of current mental health treatment among university students with a schizophrenia spectrum disorder. Early Interv Psychiatry. 2023 Dec; 17(12):1207-1215.View Related Profiles. PMID: 37081818; DOI: 10.1111/eip.13422;
     
  3. Gouse BM, Boliver EE, Oblath R, Camacho L, Brown HE. Cannabis use among patients presenting to the emergency department for psychosis: Associations with restraint use, medication administration, psychiatric hospitalization, and repeat visits. Psychiatry Res. 2023 May; 323:115151.View Related Profiles. PMID: 36934468
     
  4. Gouse BM, Boliver EE, Oblath R, Camacho L, Brown HE. Cannabis use among patients presenting to the emergency department for psychosis: Associations with restraint use, medication administration, psychiatric hospitalization, and repeat visits. Psychiatry Res. 2023 Mar 17; 323:115151.View Related Profiles. PMID: 36934468
     
  5. Gouse BM, Kline ER. Clinical insights: Preventing psychosis treatment disengagement. Schizophr Res. 2023 Feb; 252:64-66.View Related Profiles. PMID: 36628870; PMCID: PMC10593115; DOI: 10.1016/j.schres.2022.12.027;
     
  6. Gouse BM, Brown HE. Improving Outcomes in Schizophrenia-A Case for Initiation of Long-Acting Antipsychotics in Early-Phase Illness. JAMA Netw Open. 2022 Jul 01; 5(7):e2224172.View Related Profiles. PMID: 35900769
     
  7. Schor SH, Gibbs JS, Gouse BM, Brown HE. A call to action: Increased mortality from COVID-19 among individuals with schizophrenia calls for coordinated vaccination efforts. Schizophr Res. 2022 Aug; 246:63-64.View Related Profiles. PMID: 35716577; PMCID: PMC9167853; DOI: 10.1016/j.schres.2022.06.002;
     
  8. Gouse BM, Nieves-Archibald A, Trutzer I, Rezvani M, Srinath M, Chang A, Wilensky D, Duncan A. Pediatric Malignant Catatonia Associated With Vaporized Cannabis Use: A Case Series. J Acad Consult Liaison Psychiatry. 2021 Jul-Aug; 62(4):445-448.View Related Profiles. PMID: 34210403
     
  9. Gouse BM, Spears WE, Nieves Archibald A, Montalvo C. Catatonia in a hospitalized patient with COVID-19 and proposed immune-mediated mechanism. Brain Behav Immun. 2020 10; 89:529-530.View Related Profiles. PMID: 32791211; PMCID: PMC7416728; DOI: 10.1016/j.bbi.2020.08.007;
     
  10. Gouse BM, Chang AL, Smith EG. Effect Size and Blinding in Lumateperone Trial. JAMA Psychiatry. 2020 06 01; 77(6):650-651. PMID: 32320009
     
Showing 10 of 17 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 16 publications over 9 distinct years, with a maximum of 3 publications in 2014 and 2023

YearPublications
20143
20151
20171
20182
20202
20211
20222
20233
20241

2022 Boston Medical Center: Gennaro Acampora Junior Investigator Award
2022 Boston Medical Center: Resident Research Award
2022 Boston Medical Center: Rising to the Occassion Staff Recognition Award
2021 Boston Medical Center: Gennaro Acampora Junior Investigator Award
2021 American Psychiatric Association : Research Colloquium: Health Disparities and Health Services Research
2021 American Psychiatric Association: Resident Recognition Award

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
  • Co-Mentor or Peer Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

771 Albany St
Boston MA 02118
Google Map


Gouse's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department